Jason Paltrowitz

Executive Vice President, Corporate Services

OTC Markets Group

Responsible at OTC Markets for all international and domestic corporate services new business and relationship management.

Call Rates

Duration Price
6 minutes (SixFree Call) $0 (No charge)

Tags

Corporate Services Small-Cap Companies Capital Markets Securities Financial Markets Equities Investments Emerging Markets Trading Equity Trading Financial Risk Fixed Income Derivatives Mergers & Acquisitions

Biography

Jason Paltrowitz is Executive Vice President, Corporate Services at OTC Markets Group, where he is responsible for managing the firm’s international and domestic Corporate Services business. Drawing upon his expertise in cross-border trading and as a recognized proponent of Reg A+ and small company capital raising, Jason is an advocate for small cap issuers, start-ups, and entrepreneurial innovators working to alleviate the cost, time and complexity associated with being a public company. Prior to joining OTC Markets in October 2013, Jason was Managing Director and Segment Head at JP Morgan Chase responsible for the custody, clearing and collateral management business in the Corporate and Investment Bank division. Jason also held multiple senior management positions at BNY Mellon, most notably, as Head of M&A for the Financial Markets and Treasury Services Sector and 11 years as the Head of the Global Capital Markets Group in the Depositary Receipt Division. Jason currently serves on the Board of Directors of the Crowdfunding Professional Association (CfPA) and also served as a member of the Board of Directors at OTC Markets Group from 2008 – 2011. Jason holds a Bachelor's degree in International Relations from Boston University and received his MBA from the NYU Stern School of Business.

 

 

Experience

Executive Vice President, Corporate Services

OTC Markets Group
February 2015 - present

OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors. To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.

Managing Director & Global Head of Business Development, Corporate Services

OTC Markets Group
October 2013 - January 2015

Managing Director, Segment Head Bank / Broker Dealer Market, Worldwide Securities Services

JP Morgan Chase & Co.
June 2011 - August 2013

For over 200 years, JPMorgan Chase & Co has provided innovative financial solutions for consumers, small businesses, corporations, governments and institutions around the world.

Today, we're a leading global financial services firm with operations servicing clients in more than 100 countries.

Whether we are serving customers, helping small businesses, or putting our skills to work with partners, we strive to identify issues and propose solutions that will propel the future and strengthen both our clients and our communities.

© 2017 JPMorgan Chase & Co. JPMorgan Chase is an equal opportunity and affirmative action employer Disability/Veteran.

Education

NYU Stern School of Business

Master of Business Administration (M.B.A.)
1999 - 2002

Harvard Business School Executive Education

2015 - 2015

Boston University

Bachelor's Degree
1990 - 1994

Other

Publications

Volunteer

iMentor

Mentor (Children)
September 2014 - present

11/15/2017 7:48:35 AM,
Jason Paltrowitz replied:

We stand ready to have ICOs trade on our market as they become registered securities.  In that respect, yes.  I think we are the natural marketplace choice for these type of securities.  Similar to why GBTC chose us for their public market. 

What percent, if any, of OTC companies are pre-revenue?

I'm wondering how early it makes sense for a company to seek an OTC listing. Perhaps stage of revenue is one indicator. What percent, if any, of OTC companies are pre-revenue? 

10/17/2017 11:46:46 AM,
Jason Paltrowitz replied:

Approx. 15% of OTCQB/OTCQX companies are pre-revenue